BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36936138)

  • 1. Letrozole cotreatment improves the follicular output rate in high-body-mass-index women with polycystic ovary syndrome undergoing IVF treatment.
    Liu Y; Lin J; Shen X; Zhu Q; Kuang Y
    Front Endocrinol (Lausanne); 2023; 14():1072170. PubMed ID: 36936138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment.
    Liu Y; Lin J; Chen L; Mao X; Wang L; Chen Q; Yu S; Kuang Y
    Front Physiol; 2022; 13():965210. PubMed ID: 36060673
    [No Abstract]   [Full Text] [Related]  

  • 3. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome.
    Ye H; Tian H; He W; Lyu Q; Kuang Y; Chen Q; Sun L
    Reprod Biol Endocrinol; 2018 May; 16(1):53. PubMed ID: 29807533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate in Women with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study.
    Huang J; Xie Q; Lin J; Lu X; Zhu J; Gao H; Cai R; Kuang Y
    Drug Des Devel Ther; 2019; 13():4461-4470. PubMed ID: 32099323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparison between fixed versus degressive doses of medroxyprogesterone acetate combined with letrozole in patients of progestin-primed ovarian stimulation protocol: a propensity score-matched study.
    Zhang Y; Li H; Zhu S; Jiang S; Zhao W; Wang X; Tian L; Zhao G; He N; Diao H; Cao H; Zhang C
    Front Endocrinol (Lausanne); 2023; 14():1295787. PubMed ID: 38155955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol.
    Huang TC; Huang MZ; Seow KM; Yang IJ; Pan SP; Chen MJ; Hwang JL; Chen SU
    Sci Rep; 2021 Nov; 11(1):22732. PubMed ID: 34815477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN; Peng JL; Yang J; Xu WM
    Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing
    Yang L; Liang F; Yuan Y; Luo X; Wang Q; Yao L; Zhang X
    Front Endocrinol (Lausanne); 2023; 14():1224858. PubMed ID: 37795363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments.
    Zhu X; Ye H; Fu Y
    Medicine (Baltimore); 2016 Jul; 95(28):e4193. PubMed ID: 27428219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clomiphene citrate is associated with favorable cycle characteristics but impaired outcomes of obese women with polycystic ovarian syndrome undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Medicine (Baltimore); 2017 Aug; 96(32):e7540. PubMed ID: 28796038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letrozole cotreatment progestin-primed ovarian stimulation in women undergoing controlled ovarian stimulation for in vitro fertilization.
    Wang X; Zhang Y; Diao H; Jiang S; Zhang C
    J Obstet Gynaecol Res; 2024 May; 50(5):890-898. PubMed ID: 38403851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.
    Wang Y; Chen Q; Wang N; Chen H; Lyu Q; Kuang Y
    Medicine (Baltimore); 2016 Mar; 95(9):e2939. PubMed ID: 26945402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response.
    Zhang J; Du M; Li Z; Liu W; Ren B; Zhang Y; Guan Y
    Front Endocrinol (Lausanne); 2021; 12():708704. PubMed ID: 34630325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: a randomised controlled trial.
    Dong J; Wang Y; Chai WR; Hong QQ; Wang NL; Sun LH; Long H; Wang L; Tian H; Lyu QF; Lu XF; Chen QJ; Kuang YP
    BJOG; 2017 Jun; 124(7):1048-1055. PubMed ID: 28276192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
    Tu X; You B; Jing M; Lin C; Zhang R
    Front Endocrinol (Lausanne); 2021; 12():801026. PubMed ID: 35140685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestin-primed ovarian stimulation protocol with or without letrozole for patients with normal ovarian reserve: a retrospective cohort study.
    Jiang X; Jiang S; Diao H; Deng K; Zhang C
    J Clin Pharm Ther; 2022 Apr; 47(4):469-476. PubMed ID: 34796515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Different Progestins in Women With Advanced Endometriosis Undergoing Controlled Ovarian Hyperstimulation for
    Guo H; Li J; Shen X; Cong Y; Wang Y; Wu L; Li B; Gao H; Ma M; Zhang W; Mao X; Fu Y; Lyu Q; Chai W; Kuang Y
    Front Endocrinol (Lausanne); 2020; 11():129. PubMed ID: 32265834
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial.
    Wang N; Zhu Q; Ma M; Liang Z; Tao Y; Wang Y; Kuang Y
    BMJ Open; 2020 Dec; 10(12):e038153. PubMed ID: 33268401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.